Lemaitre Vascular INC Form 4 insider transactions

Director John James O'Connor sold 3,000 shares of Lemaitre Vascular stock on November 15, 2024.

Director Martha Shadan of Lemaitre Vascular Inc. exercised stock options and sold shares on November 13, 2024.

LeMaitre Vascular's CEO, George W LeMaitre, reported a disposition of 14,320 shares of common stock.

Director Martha Shadan reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards in LeMaitre Vascular Inc.

Director John A. Roush reports acquisition of dividend equivalent rights related to restricted stock unit awards.

Director Bridget A. Ross acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

John James O'Connor, a director of LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock units.

Lawrence J. Jasinski, a director at Lemaitre Vascular, acquired dividend equivalent rights related to restricted stock unit awards on August 29, 2024.

Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

Director David B. Roberts acquired dividend equivalent rights related to restricted stock unit awards and performance share units of Lemaitre Vascular, Inc.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

David B. Roberts, a director and officer at Lemaitre Vascular, exercised stock options and sold shares of common stock on August 13, 2024.

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports exercising stock options and selling shares on August 5, 2024.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, sold 57,372 shares of common stock at a weighted average price of $86.6937 per share on July 16, 2024, under a pre-arranged 10b5-1 trading plan.

George LeMaitre, Chairman and CEO of LeMaitre Vascular, sold a total of 40,006 shares of common stock on July 12 and July 15, 2024, under a pre-arranged 10b5-1 trading plan.

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock unit and performance share unit awards.

Director John A. Roush acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

Director Bridget A. Ross reported the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Director John James O'Connor reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Director Lawrence J. Jasinski acquired dividend equivalent rights related to restricted stock unit and performance stock unit awards.

Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

David B. Roberts, a director and officer of Lemaitre Vascular, acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

Director Bridget A. Ross exercised stock options and sold shares of Lemaitre Vascular Inc. on May 16, 2024.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, sold shares of the company's common stock on May 13 and 14, 2024, and gifted shares on May 14, 2024.

John James O'Connor, a director of LeMaitre Vascular Inc., reported the disposition of 5,400 shares of common stock on May 9, 2024.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., executed multiple sales of common stock between May 6 and May 8, 2024, under a pre-arranged 10b5-1 trading plan.

David B. Roberts, a Director and President of Lemaitre Vascular, sold 5,025 shares of common stock on May 6, 2024, at a weighted average price of $75.62.